Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. R. Wijsman

Publicaties

Estimating how contouring differences affect normal tissue complication probability modelling

Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy

Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations

Clinical 3D/4D cumulative proton dose assessment methods for thoracic tumours with large motion

External validation of NTCP-models for radiation pneumonitis in lung cancer patients treated with chemoradiotherapy

Inter- and intrafractional 4D dose accumulation for evaluating ΔNTCP robustness in lung cancer

Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trial

Survival prediction for stage I-IIIA non-small cell lung cancer using deep learning

The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation

A phase 1 study in patients with advanced non-small cell lung cancer treated with stereotactic radiotherapy to the primary tumor combined with durvalumab and tremelimumab

Lees meer